Screener
Generate Biomedicines, Inc. GENB Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Generate Biomedicines, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Generate Biomedicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336437
FAQ
- What is Generate Biomedicines, Inc.'s total debt?
- Generate Biomedicines, Inc. (GENB) reported total debt of $62.63M in Q2 2026.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Generate Biomedicines, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude